| Code |
| SCPI |
| Title |
| PT. Schering Plough Indonesia Tbk |
| Address |
| Head Office | : | | | Address | : | Gedung Wisma BNI 46, Lantai 27 | | | Jln Jendral Sudirman Kav.1 Jakarta 10220. | | Phone | : | (021) 5789 7000 | | Fax | : | (021) - | | E-mail | : | sari.riska.hegar@merck.com | | Website | : | - | | Factory | : | Jl. Raya Pandaan Km. 48 | | | Pandaan | | | East Java | | Phone | : | (0343) 81618 | | Fax | : | (0343) 81050 | | E-mail | : | - | | Website | : | - |
|
| Background |
The scope of the Company activities is processing, packaging and developing pharmaceutical products for human and animal consumption, toiletries, cosmetics, household and related products. |
| Business cp product |
The scope of the Company activities is processing, packaging and developing pharmaceutical products for human and animal consumption, toiletries, cosmetics, household and related products. |
| Subsidiary affiliation |
|
| Commissioners |
| President Commissioner | : Andreas Daugaard Jorgensen | | | Commissioner | : Erwin Agung | | | Independent Commissioner | : Irsan Budianto Darmadji | | | | | | Per 31 Mar 2023 | | |
|
| Directors |
| President Director | : Daniel | | | Director | : Yuliana | | | Director | : Andri Soelastyo | | | | | | Per 31 Mar 2023 | | |
|
| Underwriter |
| PT. Inter-Pacific Corporation | | PT. Jardine Fleming Nusantara Finance | | | |
| Share registrar |
| PT. Sirca Datapro Perdana | | | |
| Share holders |
| Shareholders | Shares | % | | | | Organon LLC | 3556336 | 98.79 | | | | Public | 43664 | 1.21 | | | | | | | | | As of Mar 31, 2023 | | | | |
|
| History stocks |
Type of ListingDatePrice## of SharesTotal Listed Shares IPO @ Rp. 12,75006-Aug-19901000892800892800 Partial Listing22-Aug-199410001872001080000 Company Listing05-Jan-2001100025200003600000
|
| Other infos |
PT Schering Plough Indonesia TbkPT Merck Sharp Dohme Pharma Tbk per 6 May 2013 |
| Created date |
| 2023-08-29 10:19:48 |
| Revised date |
| 2023-08-29 10:19:48 |
| Finance |
| PT. Schering Plough Indonesia Tbk |
2023,
2022,
2021,
2020,
2019,
2018,
2017,
2016,
2015,
2014,
2013,
| Financial Statetment Date |
| Fiscal Year Ends |
| Months Covered in Income St |
| |
| Summary Covered in Income St |
| Cash and Cash Equivalents |
| Receivables |
| Inventories |
| Current Assets |
| Fixed Assets |
| Other Assets |
| Non Current Assets |
| Total Assets |
| Current Liabilities |
| Longterm Liabilities |
| Total Liabilities |
| Authorized |
| Paid-up Capital |
| Par Value |
| Paid-up Capital Shares |
| Retained Earnings |
| Total Equity |
| Minority Interest |
| |
| Summary of Income Statement |
| Total Sales |
| Cost of Good Sold |
| Gross Profit |
| Operating Profit |
| Other Income |
| Earning Before Tax |
| Tax |
| Net Income |
| Close Price |
| |
| Per Share Data (Rp) |
| Eps (annualized) |
| Book Value |
| |
| Financial Ratios |
| Debt Equity Ratio (X) |
| Roa(%) |
| Roe(%) |
| Npm(%) |
| Opm(%) |
| Gross Profit Margin (%) |
| Total Assets Turnover |
| |
| Cash Flow |
| CF from Operation Activities |
| CF from Investing Activities |
| CF from Financing Activities |
| Net Increase in Cash & Cash Equivalent |
| Cash & Cash Equivalent at Beginning of the Year |
| Cash & Cash Equivalent at The End of the Year |
|
|